Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 891 of 1,261
  1. US 8343952

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  2. US 8343725

    Method of diagnosing poor survival prognosis colon cancer using miR-10a

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  3. US 8344126

    Compositions and methods for inhibiting expression of XBP-1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  4. US 8343931

    Methods of inhibiting photoreceptor apoptosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  5. US 8344013

    Dual-acting imidazole antihypertensive agents

    Theravance, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  6. US 8343499

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  7. US 8343763

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  8. US 8343463

    Optical imaging agent

    Numira Biosciences, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  9. US 8344019

    Methods for the production of biliverdin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  10. US 8344135

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  11. US 8344138

    Triazinedione derivatives as GABAB receptor modulators

    Addex Pharma, S.A. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  12. US 8344147

    Process for preparing modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  13. US 8343998

    Triazolothiadiazole inhibitor of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  14. US 8344153

    Inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  15. US 8344125

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  16. US 8343969

    Bromo-phenyl substituted thiazolyl dihydropyrimidines

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  17. US 8343954

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  18. US 8343511

    Methods and compositions for treating inflammatory bowel disease

    RedHill Biopharma Ltd. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  19. US 8343737

    Cell culture compositions capable of producing a VEGF-binding fusion polypeptide

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  20. US 8343539

    Compounds that bind α5β1 integrin and methods of use

    Regents of the University of Minnesota · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  21. US 8343549

    Therapeutic uses of Dunaliella powder

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  22. US 8343506

    Chimeric chikungunya virus and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  23. US 8343481

    Method of preparing lung alveolar epithelial type II cells derived from embryonic stem cells

    The Board of Regents of the University of Texas System · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  24. US 8338135

    High affinity human antibodies to human IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.